Evidence map›Paper›PMID 32578934›Full record

ArticleClinical and translational medicine2020

The lnc-CITED2-2:1 inhibits metastasis via inhibiting CITED2 and epithelial-mesenchymal transition in gallbladder cancer.

Sheng Shen, Ji-Wen Wang, Bo-Hao Zheng, Xiao-Jian Ni, Zhi-Hui Gao, De-Xiang Zhang, Ping-Xiang Lu, Xiao-Ling Ni, Tao Suo, Hou-Bao Liu and 1 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. lncRNAMolecular therapy oncolytics · 2021
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Sheng ShenDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Ji-Wen WangDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Bo-Hao ZhengDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiao-Jian NiDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhi-Hui GaoDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
De-Xiang ZhangThe center of Biliary Disease Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Ping-Xiang LuThe center of Biliary Disease Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiao-Ling NiDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Tao SuoDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Hou-Bao LiuDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Han LiuDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0001-5946-5222
Sun Yat-sen University · CN

Funding

JianFeng project of Xuhui provincial commission of health and family planning SHXH201703National Natural Science Foundation of China 81872352Shanghai top priority Clinical Medical Center and Key Discipline Construction Plan 2017ZZ02007
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32578934
PMCPMC7403699
OpenAlexW3037765037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.